Human/Rat βAmyloid(40)ELISA Kit Wako Ⅱ
- for Immunochemistry
- Manufacturer :
- FUJIFILM Wako Pure Chemical Corporation
- Storage Condition :
- Keep at 2-10 degrees C.
- GHS :
-
- Structural Formula
- Label
- Packing
- SDS
Comparison
|
Product Number
|
Package Size
|
Price
|
Inventory
|
||
---|---|---|---|---|---|---|
|
|
96Tests
|
|
In stock |
|
Document
Kit component
For 96 tests
Antibody (BNT77)-coated Microtiter Plate (Anti Human Aβ [1-16] MoAb [Clone No. BNT77]) | 1 plate |
---|---|
Standard Solution (Human βAmyloid [1-40], 100 pmol/L) | 2 mL x 2 |
Standard Diluent Solution | 30 mL x 1 |
Wash Solution (20x) | 50 mL x 1 |
HRP-conjugated Antibody (BA27) Solution (Anti Human Aβ [1-40] MoAb [Clone No. BA27] F(ab’)2-HRP) | 12 mL x 1 |
TMB Solution | 12 mL x 1 |
Stop Solution | 12 mL x 1 |
Plate Seal | 3 sheets |
Features
Senile plaques are found specifically in the brain of patients with Alzheimer disease. The main component of senile plaque is β amyloid peptide (Aβ), which consists of 40 or 42 (43) amino acids. Aβ is therefore considered a potential marker for Alzheimer’s disease. As such, a method is needed to detect the level of Aβ with high sensitivity.
The kit is used to perform a sandwich ELISA assay with a highly specific monoclonal antibody developed by Takeda Pharmaceutical Company Ltd.. It enables quantification of human or rat (mouse) Aβ (40) with truncated or modified N-terminus from the brain tissue, culture supernatant, cerebrospinal fluid, as well as from the plasma which was conventionally challenging to quantify.
The F(ab)’2 fragment of the antibody (BA27) is used to recognize the C-terminal of Aβ40. As a result, non-specific binding is minimized and the stability in terms of antigen-antibody reaction has improved compared with the conventional kit*. Thus, the antibody has an improved stability even during the washing step.
Improvements from the conventional kit
- Improved stability of antigen-antibody reaction as a result of the use of F(ab)’2 fragment of the antibody (BA27) to recognize the C-terminal.
- Lower background signal for human/rats (about 1/3 of the conventional kit).
*Human βAamyloid(40) ELISA Kit Wako (Code No. 294-62501)
Performance
Correlation with the conventional kit
Normal Human Plasma (A-H) were measured using the ELISA Kit Wako Ⅱand the conventional kit. The obtained results were equivalent for the two kits.
Standard curve
Standard curves were prepared using the standard solution included in the kit.
※2-hr reaction with the HRP-conjugated antibody.
Specificity test
Sample | Cross-reactivity(%) |
---|---|
Human Aβ(1-40) | 100.0 |
Human Aβ(1-42) | ≦0.1 |
Human Aβ(1-43) | ≦0.1 |
Rat(Mouse) Aβ(1-40) | 156.0 |
Rat(Mouse) Aβ(1-42) | 0.3 |
Overview / Applications
Outline | This product is for research use only. Do not administer it to human.
These ELISA kits are detection kits that achieve more stable antigen-antibody reactions by using F(ab')2 fragment of the labeled antibody BA27, which recognizes the C-terminal of beta Amyloid 40, while the nonspecific binding is remaining to be reduced. Therefore, the stability in washing solution is improved. In the Human/Rat kit, background is reduced. *1: beta Amyloid (x-40) is beta Amyloid peptide modified or cleaved at the N-terminal. [Features]
[Kit Contents]
The product information is shown on the page 7 of Wako Product Update No. 17. |
---|
Property
Manufacturer Information
Alias
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.